HAE
$108.57
Haemonetics
($1.57)
(1.43%)
HAE
Earnings Whisper ®
N/A
4th Quarter March 2020
Consensus:  $0.75
Revenue:  $251.03 Mil
Tuesday
May 5
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when HAE reports earnings?
Beat
Meet
Miss

Where is HAE's stock price going from here?
Up
Flat
Down
Stock chart of HAE
Analysts
Summary of analysts' recommendations for HAE
Score
Grade
Pivots
Resistance
$118.74
$116.91
$113.52

$111.69

Support
$108.30
$106.47
$103.08
Tweet
Growth
Description
Haemonetics is a global company engaged in the design, manufacture and worldwide marketing of automated blood processing systems. These systems address important medical markets: surgical blood salvage, blood component collections and plasma collections. The majority of their business is outside the US.
Peers
StrykerBoston ScientificBecton, DickinsonWatersBaxter InternationalAbbott LaboratoriesTeleflex3MIntegra LifeSciences HoldingsMerit Medical Systems